However, MMS now provides a high-throughput, label-free means to monitor this transition in real time and to interrogate how environmental or post-translational factors influence seeding competence, which can be extrapolated to studying Tau aggregation pathways in tauopathies such as Alzheimer’s Disease. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.